+5 | The top 5 medtech stories for March 24, 2017

This article was originally published here


Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

Get this in your inbox everyday by subscribing to our newsletters.

5. Mirabilis Medica wins CE Mark, FDA IDE for Mirabilis system news

Uterine fibroid-treating device developer Mirabilis Medica said today it won CE Mark approval in the European Union and FDA investigational device exemption for its Mirabilis System designed to treat uterine fibroids.

The Bothell, Wash.-based company’s Mirabilis system is designed to use ultrasound to both provide imaging and ablation during procedures to remove uterine fibroids, the company said. Read more

4. Align Technology inks sales deal with Zfx news

Align Technology said today it inked a sales agreement with Zfx GmbH to expand the sales of its iTero Element intraoral scanners in European, Asian and African countries.

Through the non-exclusive deal, Zfx will act as a sales agent for the company’s iTero Element intraoral scanners amongst its network of customers, including laboratories, milling centers and dental professionals. Read more

3. Heart Societies update guidelines to support cardiac monitors for syncope patients news

Medtronic said today that new guidelines from the American College of Cardiology, the American Heart Association and the Heart Rhythm Society now recommend the use of cardiac monitors for patients with syncope.

The updated guidelines for patients with syncope, or unexplained fainting, was published online in the Journal of the American College of Cardiology, Circulation and HeartRhythmRead more

2. NuVasive shareholders win class action cert in alleged kickback case news

A federal court this week certified a class of NuVasive Inc. investors in a suit alleging that the company lost share value after it hid a kickback scheme.

A judge in the US District Court for the Southern District of California this week granted a motion for class certification, appointing Brad Mass and Daniel Popov as class representatives, according to court documents. Read more

1. Cordis recalls select S.M.A.R.T. flex vascular stent systems news

Cardinal Health subsidiary Cordis this week released an urgent field safety notice recalling its S.M.A.R.T. Flex vascular stent systems in sizes 5x200mm and 6x200mm over deployment issues.

The company is recalling the devices over reports of deployment difficulty with the devices in the 2 particular sizes. Read more

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply